Arthritis Prevention In the Pre-clinical Phase of Rheumatoid Arthritis with Abatacept: a randomised controlled trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms APIPPRA
- 01 Aug 2016 Planned End Date changed from 31 Dec 2016 to 11 Dec 2018.
- 01 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Nov 2015 Accrual to date is 13% according to the United Kingdom Clinical Research Network record.